Product information

Current status:

Cancelled Post Market

Current status date:

2007-07-31

Original market date: ^{See footnote 1}

1986-12-31

Product name:

VIPRINEX

DIN:

00657271 Electronic product monograph is not available

Company:

ABBOTT LABORATORIES, LIMITED
8401 Trans-Canada Highway
Saint-Laurent
Quebec
Canada H4S 1Z1

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intravenous ,  Subcutaneous

Number of active ingredient(s):

1

Schedule(s):

Schedule D

American Hospital Formulary Service (AHFS): ^{See footnote 3}

20:12.04.92 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

B01AD09 ANCROD

Active ingredient group (AIG) number:^{See footnote5}

0114746001